SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-048038
Filing Date
2017-02-17
Accepted
2017-02-17 16:32:55
Documents
5
Period of Report
2017-02-13
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d335637d8k.htm 8-K 14146
2 EX-3.1 d335637dex31.htm EX-3.1 15169
3 GRAPHIC g335637dsp5_1.jpg GRAPHIC 20715
4 GRAPHIC g335637dsp5_2.jpg GRAPHIC 6219
5 GRAPHIC g335637dsp5_3.jpg GRAPHIC 10145
  Complete submission text file 0001193125-17-048038.txt   82089
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 17621824
SIC: 2834 Pharmaceutical Preparations